Orthopediatrics (NASDAQ:KIDS) had its target price raised by stock analysts at Piper Jaffray Companies from $40.00 to $44.00 in a note issued to investors on Friday, The Fly reports. The brokerage presently has an “overweight” rating on the stock. Piper Jaffray Companies’ price objective points to a potential upside of 17.33% from the stock’s previous close.
Several other research firms also recently weighed in on KIDS. ValuEngine downgraded Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Thursday, August 1st. Zacks Investment Research upgraded Orthopediatrics from a “hold” rating to a “buy” rating and set a $37.00 price target on the stock in a research note on Thursday, October 10th. Finally, BidaskClub downgraded Orthopediatrics from a “buy” rating to a “hold” rating in a research note on Friday. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The company currently has a consensus rating of “Buy” and an average price target of $44.40.
Orthopediatrics stock opened at $37.50 on Friday. The company has a quick ratio of 1.75, a current ratio of 2.53 and a debt-to-equity ratio of 0.24. The stock has a market cap of $560.98 million, a price-to-earnings ratio of -39.06 and a beta of 0.23. The business has a 50-day simple moving average of $36.29 and a 200 day simple moving average of $36.98. Orthopediatrics has a 52 week low of $25.11 and a 52 week high of $47.82.
Orthopediatrics (NASDAQ:KIDS) last posted its quarterly earnings results on Thursday, November 7th. The company reported ($0.18) earnings per share for the quarter, missing the consensus estimate of ($0.17) by ($0.01). The company had revenue of $20.74 million during the quarter, compared to analysts’ expectations of $19.87 million. Orthopediatrics had a negative return on equity of 12.92% and a negative net margin of 15.77%. The business’s quarterly revenue was up 31.1% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.15) EPS. On average, research analysts anticipate that Orthopediatrics will post -0.82 earnings per share for the current year.
A number of institutional investors and hedge funds have recently modified their holdings of KIDS. Aperio Group LLC purchased a new stake in Orthopediatrics during the 2nd quarter valued at $39,000. Meadow Creek Investment Management LLC boosted its stake in shares of Orthopediatrics by 125.0% in the 2nd quarter. Meadow Creek Investment Management LLC now owns 2,160 shares of the company’s stock worth $84,000 after buying an additional 1,200 shares during the last quarter. Bank of Montreal Can boosted its stake in shares of Orthopediatrics by 56.3% in the 2nd quarter. Bank of Montreal Can now owns 2,853 shares of the company’s stock worth $112,000 after buying an additional 1,028 shares during the last quarter. Neuburgh Advisers LLC boosted its stake in shares of Orthopediatrics by 125.0% in the 2nd quarter. Neuburgh Advisers LLC now owns 2,970 shares of the company’s stock worth $116,000 after buying an additional 1,650 shares during the last quarter. Finally, Tyers Asset Management LLC boosted its stake in shares of Orthopediatrics by 125.0% in the 2nd quarter. Tyers Asset Management LLC now owns 3,780 shares of the company’s stock worth $148,000 after buying an additional 2,100 shares during the last quarter. Institutional investors and hedge funds own 49.01% of the company’s stock.
Orthopediatrics Company Profile
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, RESPONSE Spine systems, Bandloc, and Pediguard.
Further Reading: Analyzing a company’s cash flow statement
Receive News & Ratings for Orthopediatrics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthopediatrics and related companies with MarketBeat.com's FREE daily email newsletter.